Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Keding Shao
Matrine Cooperates With All-Trans Retinoic Acid on Differentiation Induction of All-Trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Cells (NB4-LR1): Possible Mechanisms
Planta Medica
Organic Chemistry
Molecular Medicine
Pharmacology
Complementary
Pharmaceutical Science
Analytical Chemistry
Alternative Medicine
Drug Discovery
Related publications
4-Oxo Retinoic Acid for Refractory Acute Promyelocytic Leukemia in Children With All-Trans Retinoic Acid Therapy.
Journal of Nutritional Science and Vitaminology
Medicine
Nutrition
Dietetics
All‐ Trans ‐Retinoic Acid Pharmacology and Its Impact on the Treatment of Acute Promyelocytic Leukemia
Oncologist
Cancer Research
Medicine
Oncology
All-Trans-Retinoic Acid Nanodisks
International Journal of Pharmaceutics
Pharmaceutical Science
Epigallocatechin-3-Gallate Promotes All-Trans Retinoic Acid-Induced Maturation of Acute Promyelocytic Leukemia Cells via PTEN
International Journal of Oncology
Cancer Research
Oncology
All-Trans Retinoic Acid and Arsenic Trioxide Fail to Derepress the Monocytic Differentiation Driver Irf8 in Acute Promyelocytic Leukemia Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Additional Chromosome Abnormalities in Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid and Chemotherapy
Haematologica
Hematology
Pharmacogenomic Analysis of Acute Promyelocytic Leukemia Cells Highlights CYP26 Cytochrome Metabolism in Differential All-Trans Retinoic Acid Sensitivity
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Pseudotumor Cerebri Associated With All-Trans Retinoic Acid Treatment in Female Patients With Acute Promyelocytic Leukemia: A Case Series
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Successful Continuous Treatment With All-Trans Retinoic Acid for Acute Promyelocytic Leukemia; Secondary Malignancy After the Treatment of Osteosarcoma.
Internal Medicine
Internal Medicine
Medicine